Healthcare
AvenCell – SUCCESS PAGE – December 15, 2025
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Developing highly targeted antibiotics that have the potential to reduce the core symptoms of Autism
Carbon GeoCapture is a global leader in the development of affordable, safe and effective carbon sequestration technology
Developing highly targeted antibiotics that have the potential to reduce the core symptoms of Autism
NextTrip (NASDAQ: NTRP) is a travel discovery and booking platform built to disrupt an industry that’s been stagnant for 30 years
Carbon GeoCapture is a global leader in the development of affordable, safe and effective carbon sequestration technology
NextTrip (NASDAQ: NTRP) is a travel discovery and booking platform built to disrupt an industry that’s been stagnant for 30 years
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers